Rapamycin Responds to Alzheimer’s Disease: A Potential Translational Therapy

Alzheimer’s disease (AD) is a sporadic or familial neurodegenerative disease of insidious onset with progressive cognitive decline. Although numerous studies have been conducted or are underway on AD, there are still no effective drugs to reverse the pathological features and clinical manifestations...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Si-Jia, Zhang, Sheng-Xiao, Li, Yang, Xu, Sui-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557994/
https://www.ncbi.nlm.nih.gov/pubmed/37810956
http://dx.doi.org/10.2147/CIA.S429440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557994/
https://www.ncbi.nlm.nih.gov/pubmed/37810956
http://dx.doi.org/10.2147/CIA.S429440

Ejemplares similares